封面
市场调查报告书
商品编码
1703390

吻合器市场-全球产业规模、份额、趋势、机会和预测(按产品、应用、最终用途、地区和竞争细分,2020-2030 年)

Anastomosis Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End-use, By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球吻合器市场价值为 36 亿美元,预计在预测期内将呈现稳定成长,到 2030 年的年复合成长率(CAGR) 为 5.28%。

市场概览
预测期 2026-2030
2024年市场规模 36亿美元
2030年市场规模 49.1亿美元
2025-2030 年复合年增长率 5.28%
成长最快的领域 一次性的
最大的市场 北美洲

近年来,医疗器材领域的技术进步显着,吻合器材的开发取得了显着进展。这些装置在外科手术过程中至关重要,可以连接两个血管或空心器官(例如肠道或输尿管),以恢復正常的生理功能。吻合装置已成为心血管、胃肠道和泌尿外科等多种外科专业中不可或缺的一部分。

受慢性病发病率上升、全球人口老化以及外科技术进步等因素推动,市场成长持续强劲。这些设备对于旁路移植、肠切除和器官移植等手术至关重要,这些手术正变得越来越频繁。

关键市场驱动因素

外科手术数量不断增加

主要市场挑战

监理复杂性

主要市场趋势

技术创新

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:顾客之声

第五章:吻合器市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按产品(一次性、可重复使用)
    • 依应用(心血管外科、胃肠外科、其他)
    • 依最终用途(医院、门诊护理中心和诊所)
    • 按地区
    • 按公司分类(2024)
  • 市场地图

第六章:北美吻合器市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章:欧洲吻合器市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第八章:亚太吻合器械市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章:南美吻合器市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章:中东与非洲吻合器市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 最新动态
  • 产品发布
  • 併购

第 13 章:全球吻合器市场:SWOT 分析

第 14 章:竞争格局

  • Medtronic plc
  • LivaNova PLC
  • MAQUET Holding BV & Co. KG.
  • Dextera Surgical Inc.
  • Vitalitec Internaional Inc.
  • Synovis Micro Companies Alliance, Inc.
  • Ethicon US, LLC
  • Peters Surgical SASU

第 15 章:策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 16735

Global Anastomosis devices market was valued at USD 3.60 billion in 2024 and is projected to exhibit steady growth over the forecast period, with a compound annual growth rate (CAGR) of 5.28% through 2030.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.60 Billion
Market Size 2030USD 4.91 Billion
CAGR 2025-20305.28%
Fastest Growing SegmentDisposable
Largest MarketNorth America

The medical devices sector has experienced significant technological advancements in recent years, with notable progress in the development of anastomosis devices. These devices are essential in surgical procedures, enabling the connection of two blood vessels or hollow organs-such as the intestines or ureters-to restore normal physiological function. Anastomosis devices have become indispensable in a variety of surgical specialties, including cardiovascular, gastrointestinal, and urological procedures.

Market growth has been consistently strong, driven by factors such as the increasing prevalence of chronic diseases, an aging global population, and advancements in surgical techniques. These devices are critical in procedures such as bypass grafting, bowel resections, and organ transplantation, all of which are becoming more frequent.

Key Market Drivers

Rising Number of Surgical Procedures

The increasing volume of surgical procedures globally is a primary factor fueling the growth of the anastomosis devices market. It is estimated that between 220 and 344 million surgeries are performed worldwide annually, with high-frequency operations such as cataract removals, cesarean deliveries, and orthopedic joint replacements accounting for a significant portion. Despite this, disparities in access to safe, timely, and affordable surgical care persist-particularly in low- and middle-income countries-posing a barrier to healthcare equity and system development.

Anastomosis devices are integral in surgeries requiring the connection of blood vessels, gastrointestinal structures, or other tubular systems. As the global demand for surgical interventions increases, so does the need for reliable, efficient, and minimally invasive anastomosis solutions.

Each year, an estimated two million patients undergo open-heart surgery to treat conditions such as coronary artery disease, valvular abnormalities, and congenital heart defects. These complex procedures often require precise vascular connections, driving the demand for high-performance anastomosis devices.

Furthermore, the global rise in chronic diseases-such as cardiovascular disorders, cancer, gastrointestinal conditions, and obesity-has led to a growing need for surgical interventions including CABG, colorectal surgery, and bariatric procedures. These often involve anastomosis and underscore the increasing preference for advanced devices that reduce operation times, minimize complications, and enhance patient outcomes. This sustained demand continues to support market growth.

Key Market Challenges

Regulatory Complexity

A major challenge for the anastomosis devices market is navigating stringent regulatory approval processes. Authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) enforce rigorous standards regarding the safety and efficacy of medical devices. Compliance with these requirements can be both time-intensive and costly, often resulting in delays to product launches and increased development expenditures for manufacturers.

Key Market Trends

Technological Innovation

Technological advancements are playing a transformative role in the anastomosis devices market, significantly enhancing surgical precision and patient outcomes. The field has witnessed major innovations that have simplified procedures and improved recovery times.

The adoption of minimally invasive surgical techniques, including robotic-assisted and laparoscopic systems, has improved the accuracy and reduced the invasiveness of complex anastomosis procedures. High-resolution visualization technologies-such as 3D imaging, augmented reality, and intraoperative imaging systems-enable surgeons to perform more precise operations with real-time feedback.

Innovations in biomaterials and tissue engineering are also reshaping the market. New materials that promote tissue regeneration and healing-such as bio-absorbable staples and tissue adhesives-are reducing post-operative risks. Advanced surgical staplers now feature adjustable staple heights, tissue-sensing capabilities, and real-time feedback systems to ensure optimal performance.

Electrosurgical devices are becoming increasingly popular for their precision and ability to minimize bleeding during tissue dissection and coagulation, leading to reduced post-surgical complications.

Key Market Players

  • Medtronic plc
  • LivaNova PLC
  • MAQUET Holding B.V. & Co. KG.
  • Dextera Surgical Inc.
  • Vitalitec Internaional Inc.
  • Synovis Micro Companies Alliance, Inc.
  • Ethicon US, LLC
  • Peters Surgical SASU

Report Scope:

In this report, the Global Anastomosis Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anastomosis Devices Market, By Product:

  • Disposable
  • Reusable

Anastomosis Devices Market, By Application:

  • Cardiovascular Surgery
  • Gastrointestinal Surgery
  • Others

Anastomosis Devices Market, By End-Use:

  • Hospitals
  • Ambulatory Care Centres & Clinics

Anastomosis Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anastomosis Devices Market.

Available Customizations:

Global Anastomosis Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Anastomosis Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Disposable, Reusable)
    • 5.2.2. By Application (Cardiovascular Surgery, Gastrointestinal Surgery, Others)
    • 5.2.3. By End-Use (Hospitals, Ambulatory Care Centers & Clinics)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Anastomosis Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End-Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Anastomosis Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-Use
    • 6.3.2. Canada Anastomosis Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-Use
    • 6.3.3. Mexico Anastomosis Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-Use

7. Europe Anastomosis Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End-Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Anastomosis Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-Use
    • 7.3.2. United Kingdom Anastomosis Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-Use
    • 7.3.3. Italy Anastomosis Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-Use
    • 7.3.4. France Anastomosis Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-Use
    • 7.3.5. Spain Anastomosis Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-Use

8. Asia-Pacific Anastomosis Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End-Use
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Anastomosis Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-Use
    • 8.3.2. India Anastomosis Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-Use
    • 8.3.3. Japan Anastomosis Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-Use
    • 8.3.4. South Korea Anastomosis Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-Use
    • 8.3.5. Australia Anastomosis Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-Use

9. South America Anastomosis Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End-Use
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Anastomosis Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-Use
    • 9.3.2. Argentina Anastomosis Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-Use
    • 9.3.3. Colombia Anastomosis Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-Use

10. Middle East and Africa Anastomosis Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End-Use
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Anastomosis Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-Use
    • 10.3.2. Saudi Arabia Anastomosis Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-Use
    • 10.3.3. UAE Anastomosis Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Anastomosis Devices Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Medtronic plc
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. LivaNova PLC
  • 14.3. MAQUET Holding B.V. & Co. KG.
  • 14.4. Dextera Surgical Inc.
  • 14.5. Vitalitec Internaional Inc.
  • 14.6. Synovis Micro Companies Alliance, Inc.
  • 14.7. Ethicon US, LLC
  • 14.8. Peters Surgical SASU

15. Strategic Recommendations

16. About Us & Disclaimer